Found 14 matching trials
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma PHASE2 This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma N/A To evaluate whether tracking changes in key blood markers over time, togeth...
Show More Location
Shenzhen Third People's Hospital
Learn More & Join Trial
A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular Carcinoma PHASE2 This is a single term, open label, single Center, Phase II Trial. The study...
Show More Location
Multiple Locations
Learn More & Join Trial
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma NA This study intends to evaluate the efficacy and safety of blank- microspher...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL) PHASE2 To estimate the safety and efficacy of hepatic artery infusion chemotherapy...
Show More Location
Eastern Hepatobiliary Surgery Hospital
Learn More & Join Trial
Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer PHASE2 For advanced unresectable intrahepatic cholangiocarcinoma and gallbladder c...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC NA This study intends to evaluate the efficacy and safety of blank- microspher...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world Study N/A In recent years, immunotherapy represented by PD-1/PD-L1 inhibitors has con...
Show More Location
Multiple Locations
Learn More & Join Trial
HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT NA This study intends to evaluate the efficacy and safety of hepatic arterial ...
Show More Location
Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial